These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 33812160)
21. Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia. Zhang JP; Lencz T; Geisler S; DeRosse P; Bromet EJ; Malhotra AK Schizophr Res; 2013 May; 146(1-3):285-8. PubMed ID: 23433505 [TBL] [Abstract][Full Text] [Related]
22. Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics. Yang L; Chen J; Li Y; Wang Y; Liang S; Shi Y; Shi S; Xu Y World J Biol Psychiatry; 2016 Sep; 17(6):467-74. PubMed ID: 26982812 [TBL] [Abstract][Full Text] [Related]
23. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116 [TBL] [Abstract][Full Text] [Related]
24. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563 [TBL] [Abstract][Full Text] [Related]
25. Association of Rana S; Sultana A; Bhatti AA J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502573 [TBL] [Abstract][Full Text] [Related]
26. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Green MJ; Matheson SL; Shepherd A; Weickert CS; Carr VJ Mol Psychiatry; 2011 Sep; 16(9):960-72. PubMed ID: 20733577 [TBL] [Abstract][Full Text] [Related]
27. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis. Bora E Psychol Med; 2019 Sep; 49(12):1971-1979. PubMed ID: 31284882 [TBL] [Abstract][Full Text] [Related]
28. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease. Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653 [TBL] [Abstract][Full Text] [Related]
29. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia. Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493 [TBL] [Abstract][Full Text] [Related]
30. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics. Chiou YJ; Huang TL World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618 [TBL] [Abstract][Full Text] [Related]
31. A Retrospective Chart Review of Screening on the Prevalence of Metabolic Syndrome (MetS) in an Irish Community Mental Health Service. Cocoman AM; Gallagher D Issues Ment Health Nurs; 2019 Oct; 40(10):895-901. PubMed ID: 31295053 [TBL] [Abstract][Full Text] [Related]
32. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies. Kheirollahi M; Kazemi E; Ashouri S Cell Mol Neurobiol; 2016 Jan; 36(1):1-10. PubMed ID: 26134309 [TBL] [Abstract][Full Text] [Related]
34. Effects of antipsychotics on the serum BDNF levels in schizophrenia. Chen CC; Huang TL Psychiatry Res; 2011 Oct; 189(3):327-30. PubMed ID: 21320726 [TBL] [Abstract][Full Text] [Related]
35. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation. Pedrini M; Chendo I; Grande I; Lobato MI; Belmonte-de-Abreu PS; Lersch C; Walz J; Kauer-Sant'anna M; Kapczinski F; Gama CS Neurosci Lett; 2011 Mar; 491(3):207-10. PubMed ID: 21256922 [TBL] [Abstract][Full Text] [Related]
36. Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics? Lin EC; Shao WC; Yang HJ; Yen M; Lee SY; Wu PC; Lu RB Metab Brain Dis; 2015 Feb; 30(1):107-13. PubMed ID: 25034455 [TBL] [Abstract][Full Text] [Related]
37. Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics. Bai YM; Chen TT; Liou YJ; Hong CJ; Tsai SJ Schizophr Res; 2011 Feb; 125(2-3):179-86. PubMed ID: 21185157 [TBL] [Abstract][Full Text] [Related]
39. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Pirildar S; Gönül AS; Taneli F; Akdeniz F Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697 [TBL] [Abstract][Full Text] [Related]
40. Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study. Kudlek Mikulic S; Mihaljevic-Peles A; Sagud M; Bajs Janovic M; Ganoci L; Grubisin J; Kuzman Rojnic M; Vuksan Cusa B; Bradaš Z; Božina N Nord J Psychiatry; 2017 Oct; 71(7):513-520. PubMed ID: 28671000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]